We have located links that may give you full text access.
Investigation of Gender Differences and Exclusive Criteria in a Diabetic Acute Ischemic Stroke Population Treated with Recombinant Tissue-Type Plasminogen Activator (rtPA).
Journal of Vascular and Interventional Neurology 2017 December
Background: Many studies have reported that women who survive stroke have less favorable outcomes than men in the use of rtPA, while others reported worse outcomes in men than women. The gender difference in the exclusion criteria in a diabetic stroke population is not fully understood. This issue was investigated in this study.
Method: In a diabetic stroke population from a stroke registry of data collected between January 2010 to June 30, 2016, the gender difference was determined using demographics and clinical factors. Comparison was determined using univariate analysis while multivariable model was used to adjust for the effect of confounding variables.
Results: In a diabetic stroke population of 439 patients, more females were excluded than males ( P < 0.0001, OR = 2.323). The male exclusion was associated with atrial fibrillation ( P = 0.011, OR = 3.697), carotid artery stenosis ( P = 0.023, OR = 5.001), and cholesterol reducer ( P = 0.037, OR = 0.409). In the female diabetic stroke population, exclusion from rtPA therapy was associated with language disturbances ( P = 0.039, OR = 0.372), history of previous stroke ( P = 0.005, OR = 3.276), antihypertensive medication use ( P = 0.013, OR = 0.163), and antidiabetic medication use ( P = 0.031, OR = 0.324).
Conclusion: In a stroke population, women have a worse outcome than men in an untreated acute ischemic stroke population, but when treated there is no significant difference, suggesting a better treatment outcome for women compared to men. In a diabetic stroke population, the clinical variables for the exclusion criteria for women and men are significantly different, even after adjustment for confounding variables.
Method: In a diabetic stroke population from a stroke registry of data collected between January 2010 to June 30, 2016, the gender difference was determined using demographics and clinical factors. Comparison was determined using univariate analysis while multivariable model was used to adjust for the effect of confounding variables.
Results: In a diabetic stroke population of 439 patients, more females were excluded than males ( P < 0.0001, OR = 2.323). The male exclusion was associated with atrial fibrillation ( P = 0.011, OR = 3.697), carotid artery stenosis ( P = 0.023, OR = 5.001), and cholesterol reducer ( P = 0.037, OR = 0.409). In the female diabetic stroke population, exclusion from rtPA therapy was associated with language disturbances ( P = 0.039, OR = 0.372), history of previous stroke ( P = 0.005, OR = 3.276), antihypertensive medication use ( P = 0.013, OR = 0.163), and antidiabetic medication use ( P = 0.031, OR = 0.324).
Conclusion: In a stroke population, women have a worse outcome than men in an untreated acute ischemic stroke population, but when treated there is no significant difference, suggesting a better treatment outcome for women compared to men. In a diabetic stroke population, the clinical variables for the exclusion criteria for women and men are significantly different, even after adjustment for confounding variables.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app